Lycopene and Lutein Inhibit Proliferation in Rat Prostate Carcinoma Cells
- 20 July 2007
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 58 (2) , 171-177
Abstract
Consumption of lycopene, a carotenoid without provitamin A activity, has been associated with a lower risk of prostate and breast cancer. Lutein is another carotenoid that may be associated with a reduced risk of age-related macular degeneration, the leading cause of blindness in adults 65 years of age and older. Bioactive compounds such as lycopene and lutein, derived from natural plant sources, have been shown to act at low substrate levels through the action of intrinsic cytokines and growth factors and their receptors within tissues, particularly those of the fibroblast growth factor and transforming growth factor β families. The effects of grapefruit-derived and commercial lycopene and lutein preparations on androgen independent cultured malignant type II tumor cells [Dunning R3327AT3 or AT3 cells (androgen-responsive, slow-growing tumor cells with well developed epithelium and stroma)] were compared to their benign parent type I tumor epithelial cells (DTE). Results demonstrated that both lycopene, in an α -cyclodextrin water soluble carrier, and lutein inhibited malignant AT3 cells in a concentration and time-dependent manner. No such effect was observed when benign DTE cells were examined, demonstrating selective inhibition of extremely malignant AT3 prostate cancer cells relative to their benign parent. Lutein demonstrated a similar but slightly diminished response as lycopene. When cells were treated with cocktails of lycopene and lutein, no synergistic or additive effect occurred. These studies are consistent with epidemiological studies that show inverse relationships of these carotenoids with prostate cancer.Keywords
This publication has 28 references indexed in Scilit:
- Irradiation and storage influence on bioactive components and quality of early and late season ‘Rio Red’ grapefruit (Citrus paradisi Macf.)Postharvest Biology and Technology, 2004
- Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosisOncogene, 2003
- Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E–cdk2 complexesOncogene, 2001
- Lycopene in Association with α-Tocopherol Inhibits at Physiological Concentrations Proliferation of Prostate Carcinoma CellsBiochemical and Biophysical Research Communications, 1998
- Lycopene: A Biologically Important Carotenoid for Humans?Archives of Biochemistry and Biophysics, 1996
- Intake of Carotenoids and Retino in Relation to Risk of Prostate CancerJNCI: Journal of the National Cancer Institute, 1995
- Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3)Endocrinology, 1995
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group1994
- Lycopene as the most efficient biological carotenoid singlet oxygen quencherArchives of Biochemistry and Biophysics, 1989
- Modification of the X-irradiation syndrome by lycopene*1Experimental Cell Research, 1959